Menu
US
Application Note

Streamlining the development of bispecific antibodies from expression to quality assessment with Revvity's biotherapeutic workflow solutions

bsabs512

In this application note we show how the CHOSOURCE™ TnT Transposon Technology was used to express an asymmetric 4-chain bispecific antibody in the CHOSOURCE GS KO host cell line.

Additionally, Revvity’s LabChip GXII Touch HT system is used to rapidly characterize the expressed proteins, showing that in combination with CHOSOURCE, biotherapeutic workflows can be streamlined and accelerated.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Streamlining the development of bispecific antibodies from expression to quality assessment with Revvity's biotherapeutic workflow solutions

Download Application Note